Komori
Nagaileben (7447) · InitiativeAdvanced

Overseas materials development leveraging preferential tariffs under EPAs and FTAs

First written in FY2019. 3 of 6 entries say "Restated". Latest entry: FY2025.

6entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY2023AdvancedFY2024 – FY20252019: 12020: 120202021: 020212022: 120222023: 120232024: 120242025: 12025
Same theme, other companies
Development of Products Using Overseas Materials and Garment Manufacturing under EPAs and FTAsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2025AdvancedAnnual report

    「During the current consolidated fiscal year, the Company developed overseas materials using preferential tax treatment under EPAs and FTAs and launched strategic new products for the volume segment combining overseas materials with overseas sewing.」

    It has progressed from developing overseas materials using EPAs and FTAs to launching strategic products for the volume segment combined with overseas sewing.
  2. FY2024AdvancedAnnual report

    「During the current consolidated fiscal year, the Company developed overseas materials using preferential tax treatment under EPAs and FTAs. In the following fiscal year, it plans to launch strategic new products for the volume segment combining overseas materials with overseas sewing.」

    It developed overseas materials using EPAs and FTAs and plans to launch strategic products for the volume segment in the following fiscal year, combining overseas materials with overseas sewing.
  3. FY2023RestatedAnnual report

    「During the current consolidated fiscal year, the Company developed overseas materials using preferential tax treatment under EPAs and FTAs.」

    It continues to pursue the development of overseas materials using EPAs and FTAs as a research and development measure.
  4. FY2022RestatedAnnual report

    「During the current consolidated fiscal year, the Company developed overseas materials using preferential tax treatment under EPAs and FTAs.」

    It continues to pursue the development of overseas materials using EPAs and FTAs as a research and development measure.
  5. FY2020RestatedAnnual report

    「The Company developed overseas materials using preferential tax treatment under EPAs and FTAs.」

    It continues to pursue the development of overseas materials using EPAs and FTAs as a research and development measure.
  6. FY2019First statedAnnual report

    「During the current consolidated fiscal year, the Company developed overseas materials using preferential tax treatment under EPAs and FTAs.」

    It describes for the first time the development of overseas materials using preferential tax treatment under EPAs and FTAs as a specific research and development measure.
Moved together

"Treasury Share Acquisitions and Holdings" moved the same way as this thread, in the same document, in 2 of its 6 moves.

222222★123456
  1. ★This thread
  2. 1Treasury Share Acquisitions and Holdings2×
  3. 2Developing Overseas Business with a Focus on East Asia2×
  4. 3Market penetration of the reusable environmentally friendly medical material “Compel Pack”2×
  5. 4High Equity Ratio2×
  6. 5Exchange-Rate Fluctuations and Foreign Exchange Losses2×
  7. 6Continuation of Research and Development Activities2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Nagaileben's next results are scheduled for 2026-10-01. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Overseas materials development leveraging preferential tariffs under EPAs and FTAs | NAGAILEBEN Co.,Ltd. (7447) | Komori